Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia; Hanoi University of Pharmacy, Hanoi, Vietnam.
Allergy and Lung Health Unit, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
Lancet Respir Med. 2021 Apr;9(4):387-396. doi: 10.1016/S2213-2600(20)30413-6. Epub 2020 Nov 17.
Longitudinal trajectories of asthma and allergies from childhood to adulthood might be differentially associated with lung function and chronic obstructive pulmonary disease (COPD), but associations with extrapulmonary comorbidities have not been well investigated. We aimed to assess these trajectories and examine their associations with lung function outcomes and profiles of comorbidities.
In this prospective cohort study, data for asthma and related allergic conditions (ie, eczema, hay fever, and food allergy) were prospectively collected from the Tasmanian Longitudinal Health Study for participants aged 7-53 years originally recruited in Tasmania, Australia. All surviving individuals in the database with contact details were invited in the most recent follow-up (mean age 53 years). There were no exclusion criteria. With use of latent class analysis, we identified longitudinal trajectories of asthma and allergic conditions from 7-53 years, and profiles of self-reported extrapulmonary conditions recorded at 53 years. The associations between asthma and allergy trajectories and morbidity profiles and lung function at 53 years were investigated with regression models.
Between Sept 3, 2012, and Nov 8, 2016, of 6128 individuals invited, 3609 (58·9%) individuals were enrolled. We identified five asthma and allergy trajectories: minimal and least asthma and allergies (n= 1767 [49·0%]); late-onset hay fever, no asthma (n=1065 [29·5%]); early-onset remitted asthma and allergies (n=236 [6·5%]); late-onset asthma and allergies (n=317 [8·8%]); and early-onset persistent asthma and allergies (n=224 [6·2%]); and four profiles of extrapulmonary morbidities: minimal or least disease (n=2206 [61·1%]); dominant mental health disorders (n=861 [23·9%]); dominant cardiovascular diseases or risks (n=424 [11·7%]); and multiple disorders (n=117 [3·2%]). The late-onset asthma and allergies trajectory was predominantly associated with the multiple disorders profile (relative risk ratio 3·3 [95% CI 1·9-5·9]), whereas the other asthma and allergy trajectories were associated only with the dominant mental health disorders profile. Both spirometrically defined and clinical COPD were most strongly associated with the early-onset persistent asthma and allergies trajectory (odds ratio [OR] 5·3 [95% CI 3·2-8·6]) and also with the late-onset asthma and allergies trajectory (OR 3·8 [2·4-6·1]).
Distinct longitudinal trajectories of asthma and allergic disease from childhood to 53 years are associated with different profiles of extrapulmonary comorbidities and varying risk of COPD. These findings can inform a personalised approach in clinical guidelines and management focusing on treatable traits. Comorbidity profiles are a new target for early identification and intervention.
National Health and Medical Research Council of Australia, EU's Horizon 2020, The University of Melbourne, Clifford Craig Medical Research Trust of Tasmania, The Victorian, Queensland & Tasmanian Asthma Foundations, The Royal Hobart Hospital, Helen MacPherson Smith Trust, and GlaxoSmithKline.
从儿童期到成年期的哮喘和过敏的纵向轨迹可能与肺功能和慢性阻塞性肺疾病(COPD)的相关性不同,但与肺外合并症的相关性尚未得到充分研究。我们旨在评估这些轨迹,并研究它们与肺功能结果和合并症特征之间的关系。
在这项前瞻性队列研究中,从澳大利亚塔斯马尼亚州最初招募的年龄在 7-53 岁的塔斯马尼亚纵向健康研究中前瞻性收集了哮喘和相关过敏情况(即湿疹、花粉热和食物过敏)的数据。数据库中所有有联系信息的幸存个体都在最近的随访中被邀请(平均年龄 53 岁)。没有排除标准。使用潜在类别分析,我们从 7-53 岁识别出哮喘和过敏情况的纵向轨迹,以及 53 岁时自我报告的肺外疾病特征。使用回归模型研究哮喘和过敏轨迹与发病率特征以及 53 岁时的肺功能之间的关系。
在 2012 年 9 月 3 日至 2016 年 11 月 8 日之间,邀请了 6128 人,其中 3609 人(58.9%)参加了研究。我们确定了五种哮喘和过敏轨迹:最小和最少的哮喘和过敏(n=1767[49.0%]);迟发性花粉热,无哮喘(n=1065[29.5%]);早发性缓解的哮喘和过敏(n=236[6.5%]);迟发性哮喘和过敏(n=317[8.8%]);早发性持续的哮喘和过敏(n=224[6.2%]);以及四种肺外疾病特征:最小或最少的疾病(n=2206[61.1%]);主要精神健康障碍(n=861[23.9%]);主要心血管疾病或风险(n=424[11.7%]);和多种疾病(n=117[3.2%])。迟发性哮喘和过敏轨迹主要与多种疾病特征相关(相对风险比 3.3[95%CI 1.9-5.9]),而其他哮喘和过敏轨迹仅与主要精神健康障碍特征相关。肺功能定义的和临床 COPD 与早发性持续的哮喘和过敏轨迹(比值比[OR]5.3[95%CI 3.2-8.6])和晚发性哮喘和过敏轨迹(OR 3.8[2.4-6.1])的相关性最强。
从儿童期到 53 岁的哮喘和过敏性疾病的不同纵向轨迹与不同的肺外合并症特征以及 COPD 的不同风险相关。这些发现可以为临床指南和管理中注重可治疗特征的个性化方法提供信息。合并症特征是早期识别和干预的新目标。
澳大利亚国家卫生和医学研究委员会、欧盟地平线 2020、墨尔本大学、塔斯马尼亚州克利福德·克雷格医学研究信托基金、维多利亚州、昆士兰州和塔斯马尼亚州哮喘基金会、皇家霍巴特医院、海伦·麦克弗森·史密斯信托基金和葛兰素史克。